Today ALBO ranks # as BUY CANDIDATE.
Today ALBO ranks # as BUY CANDIDATE.

ALBO stock Albireo Pharma Inc

ALBO stock
Albireo Pharma Inc

April 23, 2019
Change 4.01%
Chart period: 2019-01-24 - 2019-04-23
VOLUME
Sell
TREND
Buy

MV LONG
Buy

MV SHORT
Sell

PIVOT
Buy

MACD
Sell

Will ALBO stock price go up or down on Thu, 25 Apr 2019?

Albireo Pharma Inc Forecast and Stock Analysis

Technical ALBO stock analysis for April 23, 2019.

Buy candidate since 2019-04-23
Shorts n/a
Cash n/a
Loans n/a
Beta 1.70
ROA -36.09

Albireo Pharma Inc gained 4.01% in the last trading day, rising from $30.67 to $31.90 The price has been going up and down for this period, and there has been a -8.2% loss for the last 2 weeks. Volume fell in the last day by -8 892 shares, and in total, 20 212 shares bought and sold for approximately $644 763.00. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Close price at the end of the last trading day (Tuesday, 23rd Apr 2019) of the ALBO stock was $31.90. This is 4.01% more than the trading day before Monday, 22nd Apr 2019.

During day the stock fluctuated 7.94% from a day low at $30.28 to a day high of $32.69.

30 day high of the ALBO stock price was $35.30 and low was $27.83.
90 day high was $35.30 and low was $21.80.
52 week high for the Albireo Pharma Inc - $37.95 and low - $19.10.

Trend

Albireo Pharma Inc lies in the lower part of a wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $30.84 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 37.43% during the next 3 months and, with 90% probability hold a price between $42.38 and $52.40 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Albireo Pharma Inc holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $31.99. On a fall, the stock will find some support from the long-term average at approximately $31.66. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Monday April 22, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 44 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Albireo Pharma Inc finds support from accumulated volume at $31.00.

Support: $31.00 Price: $31.90 Resistance: $32.05

Risk

This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $2.40 between high and low, or 7.94%. For the last week the stock has had a daily average volatility of 5.50%.

Our recommended stoploss: $30.40 (-4.70%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation: Buy Candidate

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Buy Candidate.

Today ALBO ranks # as BUY CANDIDATE.
Today ALBO ranks # as BUY CANDIDATE.